Acute low single dose of apomorphine reduces periodic limb movements but has no significant effect on sleep arousals: A preliminary report

Neurophysiologie Clinique

Volumn 33, Issue 4, 2003, Pages 180-184

  Haba Rubio, José ^a,c   Staner, Luc ^a   Cornette, Françoise ^a   Lainey, Erik ^a   Luthringer, Rémy ^a   Krieger, Jean ^b   Macher, Jean P ^a  

^a FORENAP   (France)

^b UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^c CVP Montana HUG Genève   (Switzerland)

Author keywords

Apomorphine; Arousal; Periodic limb movements

Indexed keywords

APOMORPHINE; DOPAMINE;

ADULT; AROUSAL; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DOPAMINERGIC SYSTEM; FEMALE; HUMAN; MALE; PERIODIC LIMB MOVEMENT; RESTLESS LEGS SYNDROME; SLEEP;

EID: 0141867705     PISSN: 09877053     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0987-7053(03)00056-X     Document Type: Article

References (18)

1. ASDA: Diagnostic Classification Steering Committee. International classifications of sleep disorders: diagnostic and coding manual. Rochester, Minnesota: American Sleep Disorders Association; 1990.
2. ASDA: American Sleep Disorders Association Report. EEG arousals: scoring rules and examples. Sleep 1992;15:174-84.
3. Bonnet MH. Sleep restoration as a function of periodic awakening, movement of electroencephalographic change. Sleep 1987;10:364-73.
4. Cianchetti C, Masala C, Mangoni A, Gessa GL. Suppression of REM and delta sleep by apomorphine in man: a dopamine mimetic effect. Psychopharmacology 1980;67(1):61-5.
5. Coleman RM. Periodic leg movements in sleep (nocturnal myoclonus) and restless legs syndrome. In: Guilleminault C, editor. Sleeping and waking disorders. Menlo Park, CA: Addison-Wesley; 1982. p. 265-95.
6. Colosimo C, Merello M, Albanese A. Clinical usefulness of apomorphine in movement disorders. Clin Neuropharmacol 1994;17(3):243-59.
7. Exar EN, Collop NA. The association of upper airway resistance with periodic limb movements. Sleep 2001;24(2):188-92.
8. Hening WA, Allen RP, Walters AS, Chokoverty S. Motor functions and dysfunctions of sleep. 2nd ed. In: Chokoverty S, editor. Sleep disorders medicine. Boston: Butterworth Heinemann: 1999. p. 441-507.
9. Hening W, Allen R, Earley C, Kushida C, Picchietti D, Silber M. The treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Review. Sleep 1999;22:970-99.
10. Karadeniz D, Ondze B, Besset A, Billiard M. EEG arousals and awakenings in relation with periodic leg movements during sleep. J Sleep Res 2000;9:273-7.
11. Montplaisir J, Boucher S, Gosselin A, Poirier G, Lavigne G. Persistence of repetitive EEG arousals (K-Alpha Complexes) in RLS patients treated with L-Dopa. Sleep 1996;19:196-9.
12. Nicolle E, Pollak P, Serre-Debeauvais F, Richard P, Gervason CL, Broussolle E. et al. Pharmacokinetics of apomorphine in parkinsonians patients. Fund Clin Pharmacol 1993;7:245-52.
13. Paradiso G, Khan F, Chen R. Effects of apomorphine on flexor reflex I and periodic limb movement. Mov Disord 2002;17(3):594-7.
14. Rechtschaffen A, Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages in human subjects. Washington: US Government Printing Office: 1968.
15. Reuter I, Ellis CM, Ray Chaudhuri K. Nocturnal subcutaneous apomorphine infusion in Parkinson's disease and restless legs syndrome. Acta Neurol Scand 1999;100:163-7.
16. Stepanski J, Lamphere J, Badia P, Zorik F, Roth T. Sleep fragmentation and daytime sleepiness. Sleep 1984;7(1):18-26.
17. Walters AS. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord 1995:10(5):634-42.
18. Walters AS, Winkelmann J, Trenkwalder C, Fry JM, Kataria V, Wagner M, et al. Long-term follow-up on restless legs syndrome patients treated with opioids. Mov Disord 2001;16(6):1105-9.